Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression.

MLA

Zhang, Zhan-Sheng, et al. “Andrographolide Sensitizes Glioma to Temozolomide by Inhibiting DKK1 Expression.” British Journal of Cancer, vol. 131, no. 8, Nov. 2024, pp. 1387–98. EBSCOhost, https://doi.org/10.1038/s41416-024-02842-0.

APA

Zhang, Z.-S., Gao, Z.-X., He, J.-J., Ma, C., Tao, H.-T., Zhu, F.-Y., Cheng, Y.-N., Xie, C.-Q., Li, J.-Q., Liu, Z.-Z., Hou, L.-L., Sun, H., Xie, S.-Q., & Fang, D. (2024). Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression. British Journal of Cancer, 131(8), 1387–1398. https://doi.org/10.1038/s41416-024-02842-0

Chicago

Zhang, Zhan-Sheng, Zi-Xuan Gao, Jin-Jin He, Can Ma, Hang-Tian Tao, Feng-Yi Zhu, Yu-Na Cheng, et al. 2024. “Andrographolide Sensitizes Glioma to Temozolomide by Inhibiting DKK1 Expression.” British Journal of Cancer 131 (8): 1387–98. doi:10.1038/s41416-024-02842-0.